PerkinElmer, Inc. (PKI): Price and Financial Metrics
PerkinElmer, Inc. (PKI)
Today's Latest Price: $124.86 USD
Updated Oct 1 4:03pm
Add PKI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 140 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
PKI Stock Summary
- PKI has a market capitalization of $14,033,839,903 -- more than approximately 88.05% of US stocks.
- Perkinelmer Inc's stock had its IPO on January 1, 1986, making it an older stock than 92.88% of US equities in our set.
- The price/operating cash flow metric for Perkinelmer Inc is higher than 86.02% of stocks in our set with a positive cash flow.
- Stocks that are quantitatively similar to PKI, based on their financial statements, market capitalization, and price volatility, are MYL, WAB, HUN, XYL, and HOLX.
- PKI's SEC filings can be seen here. And to visit Perkinelmer Inc's official web site, go to www.perkinelmer.com.
PKI Stock Price Chart Technical Analysis Charts
PKI Price/Volume Stats
| Current price | $124.86 | 52-week high | $128.98 |
| Prev. close | $125.51 | 52-week low | $62.91 |
| Day low | $123.66 | Volume | 1,149,598 |
| Day high | $128.98 | Avg. volume | 892,553 |
| 50-day MA | $118.14 | Dividend yield | 0.22% |
| 200-day MA | $98.54 | Market Cap | 13.96B |
PerkinElmer, Inc. (PKI) Company Bio
PerkinElmer Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates through two segments, Human Health and Environmental Health. The company was founded in 1931 and is based in Waltham, Massachusetts.
PKI Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $124.86 | $57.19 | -54% |
We started the process of determining a valid price forecast for Perkinelmer Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Perkinelmer Inc ranked in the 27th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Perkinelmer Inc, consider:
- The company's debt burden, as measured by earnings divided by interest payments, is 4.01 -- which is good for besting 53.12% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
- 87% of the company's capital comes from equity, which is greater than 71.92% of stocks in our cash flow based forecasting set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -55% |
| 1% | -55% |
| 2% | -54% |
| 3% | -54% |
| 4% | -54% |
| 5% | -53% |
RMD, ZTS, CPIX, XRAY, and IONS can be thought of as valuation peers to PKI, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...